Metabolomic tools used in marine natural product drug discovery
- 6 February 2020
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Discovery
- Vol. 15 (4) , 499-522
Abstract
Introduction: The marine environment is a very promising resource for natural product research, with many of these reaching the market as new drugs, especially in the field of cancer therapy as well as the drug discovery pipeline for new antimicrobials. Exploitation for bioactive marine compounds with unique structures and novel bioactivity such as the isoquinoline alkaloid; trabectedin, the polyether macrolide; halichondrin B, and the peptide; dolastatin 10, requires the use of analytical techniques, which can generate unbiased, quantitative, and qualitative data to benefit the biodiscovery process. Metabolomics has shown to bridge this understanding and facilitate the development of new potential drugs from marine sources and particularly their microbial symbionts. Areas covered: In this review, articles on applied secondary metabolomics ranging from 1990–2018 as well as to the last quarter of 2019 were probed to investigate the impact of metabolomics on drug discovery for new antibiotics and cancer treatment. Expert opinion: The current literature review highlighted the effectiveness of metabolomics in the study of targeting biologically active secondary metabolites from marine sources for optimized discovery of potential new natural products to be made accessible to a R&D pipeline.Keywords
This publication has 184 references indexed in Scilit:
- Looking back into the future: 30 years of metabolomics at TNOMass Spectrometry Reviews, 2013
- Quantitative 1H NMR. Development and Potential of an Analytical Method: An UpdateJournal of Natural Products, 2012
- Lessons from the Past and Charting the Future of Marine Natural Products Drug Discovery and Chemical BiologyChemistry & Biology, 2012
- MetSign: A Computational Platform for High-Resolution Mass Spectrometry-Based MetabolomicsAnalytical Chemistry, 2011
- Biologically active secondary metabolites from marine cyanobacteriaCurrent Opinion in Biotechnology, 2010
- Natural Products and Their Biological Targets: Proteomic and Metabolomic Labeling StrategiesAngewandte Chemie International Edition, 2010
- Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition researchMetabolomics, 2009
- Design and synthesis of vidarabine prodrugs as antiviral agentsBioorganic & Medicinal Chemistry Letters, 2009
- XCMS: Processing Mass Spectrometry Data for Metabolite Profiling Using Nonlinear Peak Alignment, Matching, and IdentificationAnalytical Chemistry, 2006
- Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networksComparative and Functional Genomics, 2001